Mephedrone as a new synthetic amphetamine induces abortion, morphological alterations and mitochondrial dysfunction in mouse embryos

References

• Ahmed, N., Hoy, B.P.S., and McInerney, J., 2010. Reminder of important clinical lesson: Methaemoglobinaemia due to mephedrone (‘snow’). Case reports, 2010 (oct 22 1), bcr0420102879–bcr0420102879.
   PubMedGoogle Scholar
• Alexandrescu, L. 2014. Mephedrone, assassin of youth: The rhetoric of fear in contemporary drug scares. Crime, Media, Culture, 10 (1), 23–37.
   Web of Science ®Google Scholar
• Angoa-Pérez, M., et al., 2014. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus. Life sciences, 97 (1), 31–36.
   PubMed Web of Science ®Google Scholar
• C Mariotti, K., et al., 2013. Amphetamine-type medicines: a review of pharmacokinetics, pharmacodynamics, and toxicological aspects. Current clinical pharmacology, 8 (4), 350–357.
   PubMedGoogle Scholar
• Cottencin, O., Rolland, B., and Karila, L., 2014. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. Current pharmaceutical design, 20 (25), 4106–4111.
   PubMed Web of Science ®Google Scholar
• Datnow, M.M., 1928. An Experimental Investigation Concerning Toxic Abortion Produced by Chemical Agents. BJOG: an international journal of obstetrics and gynaecology, 35 (4), 693–724.
   Google Scholar
• Dybdal-Hargreaves, N.F., et al., 2013. Mephedrone: public health risk, mechanisms of action, and behavioral effects. European journal of pharmacology, 714 (1-3), 32–40.
   PubMed Web of Science ®Google Scholar
• Emami, F., et al., 2013. Embryo Toxic Effects of Atorvastatin on Mouse Fetus. Iranian journal of pharmaceutical sciences, 9 (1), 13–23.
   Google Scholar
• Faizi, M., et al., 2016. Toxicity of cuprizone a Cu2+ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction. Toxicology mechanisms and methods, 26 (4), 276–283.
   PubMed Web of Science ®Google Scholar
• German, C.L., et al., 2014. Mephedrone alters basal ganglia and limbic neurotensin systems. Journal of neurochemistry, 130 (3), 402–407.
   PubMed Web of Science ®Google Scholar
• James, D., et al., National Poisons Information Service. 2011. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service. Emergency medicine journal: Emj, 28 (8), 686–689.
   PubMed Web of Science ®Google Scholar
• Karila, L., et al., 2015. Synthetic cathinones: a new public health problem. Current neuropharmacology, 13 (1), 12–20.
   PubMed Web of Science ®Google Scholar
• Karila, L., et al., 2016. The effects and risks associated to mephedrone and methylone in humans: a review of the preliminary evidences. Brain research bulletin, 126 (Pt 1), 61–67.
   PubMedGoogle Scholar
• Kelly, J.P., 2011. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug testing and analysis, 3 (7-8), 439–453.
   PubMed Web of Science ®Google Scholar
• Mead, J., and Parrott, A., 2020. Mephedrone and MDMA: A comparative review. Brain research, 1735, 146740.
   PubMed Web of Science ®Google Scholar
• Naseri, G., et al., 2018. Exposure to mephedrone during gestation increases the risk of stillbirth and induces hippocampal neurotoxicity in mice offspring. Neurotoxicology and teratology, 67, 10–17.
   PubMed Web of Science ®Google Scholar
• Meyer, J.N., et al., 2013. Mitochondria as a target of environmental toxicants. Toxicological sciences: an official journal of the society of toxicology, 134 (1), 1–17.
   PubMed Web of Science ®Google Scholar
• Naserzadeh, P., et al., 2019. A comparison of mitochondrial toxicity of mephedrone on three separate parts of brain including hippocampus, cortex and cerebellum. Neurotoxicology, 73, 40–49.
   PubMed Web of Science ®Google Scholar
• Palmeira, C. M., and Ramalho-Santos, J., 2017. Mitochondrial dysfunction in reproductive and developmental toxicity. Reproductive and Developmental Toxicology, 2nd Edn. academic press New york: Elsevier, p. 1023–1035.
   Google Scholar
• Pantano, F., et al., 2017. Neurotoxicity induced by mephedrone: an up-to-date review. Current neuropharmacology, 15 (5), 738–749.
   PubMed Web of Science ®Google Scholar
• Papaseit, E., et al., 2016. Human pharmacology of mephedrone in comparison with MDMA. Neuropsychopharmacology: official Publication of the american college of neuropsychopharmacology, 41 (11), 2704–2713.
   PubMed Web of Science ®Google Scholar
• Pourahmad, J., 2014. Accelerated cytotoxicity mechanism screening. Asia pacific journal of medical toxicology, 3, (Suppl 1), 4–4.
   Google Scholar
• Pourahmad, J., and O'Brien, P. J., 2000. Contrasting role of Na+ ions in modulating Cu+ 2 or Cd+ 2 induced hepatocyte toxicity. Chemico-Biological Interactions, 126 (2), 159–169.
   PubMed Web of Science ®Google Scholar
• Sadighara, M., et al., 2017. Toxicity of atorvastatin on pancreas mitochondria: a justification for increased risk of diabetes mellitus. Basic & clinical pharmacology & toxicology, 120 (2), 131–137.
   PubMed Web of Science ®Google Scholar
• Saghir, S.A., and Dorato, M.A., 2016. Reproductive and developmental toxicity testing: Examination of the extended one-generation reproductive toxicity study guideline. Regulatory toxicology and pharmacology : Rtp, 79, 110–117.
   PubMed Web of Science ®Google Scholar
• Salimi, A., Nikoosiar Jahromi, M., and Pourahmad, J., 2019. Maternal exposure causes mitochondrial dysfunction in brain, liver, and heart of mouse fetus: an explanation for perfluorooctanoic acid induced abortion and developmental toxicity. Environmental toxicology, 34 (7), 878–885.
   PubMed Web of Science ®Google Scholar
• Sengupta, S., et al., 2014. Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma. Clinical lymphoma, myeloma & leukemia, 14 (4), e111–e113.
   PubMedGoogle Scholar
• Seydi, E., et al., 2016. Selective toxicity of apigenin on cancerous hepatocytes by directly targeting their mitochondria. Anti-cancer agents in medicinal chemistry, 16 (12), 1576–1586.
   PubMed Web of Science ®Google Scholar
• Shaughnessy, D.T., et al., 2014. Mitochondria, energetics, epigenetics, and cellular responses to stress. Environmental health perspectives, 122 (12), 1271–1278.
   PubMed Web of Science ®Google Scholar
• Shen, Y., et al., 2018. The role of mitochondria in methamphetamine-induced inhibitory effects on osteogenesis of mesenchymal stem cells. European journal of pharmacology, 826, 56–65.
   PubMed Web of Science ®Google Scholar
• Sivagnanam, K., et al., 2013. "Bath salts" induced severe reversible cardiomyopathy. The American journal of case reports, 14, 288–291.
   PubMedGoogle Scholar
• Sumnall, H. R., Evans-Brown, M., and McVeigh, J., 2011. Social, policy, and public health perspectives on new psychoactive substances. Drug testing and analysis, 3 (7–8), 515–523.
   PubMed Web of Science ®Google Scholar
• Tavares, R., et al., 2016. The non-genomic effects of endocrine-disrupting chemicals on mammalian sperm. Reproduction (Cambridge, England), 151 (1), R1–R13.
   PubMed Web of Science ®Google Scholar
• Thundathil, J., Filion, F., and Smith, L.C., 2005. Molecular control of mitochondrial function in preimplantation mouse embryos. Molecular reproduction and development, 71 (4), 405–413.
   PubMed Web of Science ®Google Scholar
• Wood, D.M., et al., 2010. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. Journal of medical toxicology: official journal of the American college of medical toxicology, 6 (3), 327–330.
   PubMedGoogle Scholar